|
|
|
|
Ortho Products began operations in Montreal in 1941 with
one product and three employees. Moving to Toronto in 1944, the company outgrew a number
of rented facilities until its own facilities were constructed in 1955. Continued growth
required a number of plant expansions. McNeil products were first offered in Canada in
1948 through a distributor. Some ten years later, Johnson & Johnson acquired McNeil
Laboratories and rapid growth began. In 1991, McNeil merged with Ortho to form
Ortho-McNeil Inc.
Initially, McNeil Pharmaceutical and Ortho Pharmaceutical distributed Janssen products,
until the company was established in Canada in 1982. Growth in new products, head count
and sales were rapid for Janssen Pharmaceutica Canada and in 1995 merged to form
Janssen-Ortho Inc. The pharmaceutical industry has undergone enormous changes not only in Canada but also
throughout the world. To this influence, Janssen-Ortho has re-evaluated traditional
practices and has invested heavily in the future to deliver better treatments and services
to its customers and to the users of its products. Resources have been committed to four
key areas.
Janssen-Ortho has a long and proud history on
contributing to the management of psychotic and
central nervous system disorders. Looking after
the reproductive health of women has always
been a major commitment. Helping patients who
are suffering with anemia as a result of kidney
failure, cancer, or HIV treatments is key to the
future success of Janssen-Ortho Inc.
|
|
